Valganciclovir as CMV reactivation prophylaxis in patients...

Annals of Hematology 2009 / 12 Vol. 88; Iss. 12

Valganciclovir as CMV reactivation prophylaxis in patients receiving alemtuzumab for marrow failure syndromes

Antonio M. Risitano, Bianca Serio, Carmine Selleri, Bruno Rotoli
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
88
Language:
english
Pages:
2
DOI:
10.1007/s00277-009-0749-z
Date:
December, 2009
File:
PDF, 61 KB
english, 2009
Conversion to is in progress
Conversion to is failed